Mark N. Feinglos, MD, CM

Mark N. Feinglos, MD, CM
Professor of Medicine and Chief, Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC

M. Angelyn Bethel, MD
Assistant Professor of Medicine, Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC

Address: Mark N. Feinglos, MD, CM, Duke University Medical Center, 310A Baker House, Trent Drive, Box 3921, Durham, NC 27710; e-mail [email protected]

The authors have indicated that they have received grant or research support from Aventis Pharmaceuticals.

Mark N. Feinglos, MD, CM
Professor of Medicine and Chief, Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC

M. Angelyn Bethel, MD
Assistant Professor of Medicine, Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC

Address: Mark N. Feinglos, MD, CM, Duke University Medical Center, 310A Baker House, Trent Drive, Box 3921, Durham, NC 27710; e-mail [email protected]

The authors have indicated that they have received grant or research support from Aventis Pharmaceuticals.

Mark N. Feinglos, MD, CM
Professor of Medicine and Chief, Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC

M. Angelyn Bethel, MD
Assistant Professor of Medicine, Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC

Address: Mark N. Feinglos, MD, CM, Duke University Medical Center, 310A Baker House, Trent Drive, Box 3921, Durham, NC 27710; e-mail [email protected]

The authors have indicated that they have received grant or research support from Aventis Pharmaceuticals.